MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
76 hedge funds and large institutions have $31.4M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $61.4M → $31.4M (-$30M)
Holders
76
Holding in Top 10
–
Calls
$1.63M
Puts
$352K
Top Buyers
| 1 | +$5.45M | |
| 2 | +$2.42M | |
| 3 | +$641K | |
| 4 |
Goldman Sachs
New York
|
+$527K |
| 5 |
JGC
J. Goldman & Co
New York
|
+$491K |
Top Sellers
| 1 | -$7.69M | |
| 2 | -$2.98M | |
| 3 | -$2.71M | |
| 4 |
Renaissance Technologies
New York
|
-$1.87M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.17M |